Webhealth Logo

A Network Connecting Healthcare Professionals
WebHealthNetwork Membership: 2,384,332

EN / ES

sign up

log in

Sign Up On Webhealth Network

Sign Up On Jobs At Webhealth Network

LogIn On Webhealth Network

LogIn On Jobs At Webhealth Network

Webhealth Logo
  • Home
  • HealthCare Directory
    • US Medical Doctor Directory
    • US Nurse Directory
    • US Hospital Directory
    • US Clinic Directory
    • US Pharmacy Directory
    • US Lab Directory
  • Clinical Trials
    • Search by Name and Date
    • Clinical Trials By Letter
  • Research Articles
  • Videos
  • Solutions
  • Jobs
    • Search For Jobs Post A Job
  • About Us
  • Log-In
  • Sign-Up
Search for Clinical Trial Results

Search and View Clinical Trials by Topic

Angiomyolipoma - 12 Studies Found

Status Study
Recruiting Study Name: Clinical Presentation and Renal Outcome of Patients With Tuberous Sclerosis Complex and/or Renal Angiomyolipoma in the Great West Region of France
Condition: Tuberous Sclerosis Complex
Date: 2016-08-30
Recruiting Study Name: Sporadic Angiomyolipomas (AMLs) Growth Kinetics While on Everolimus
Condition: Sporadic Angiomyolipomas (AMLs)
Date: 2015-08-20
Interventions: Drug: Everolimus 10 mg tablets
Recruiting Study Name: Characterization of Patients With Tuberous Sclerosis Complex, Lymphangioleiomyomatosis and Angiomyolipoma
Condition: Tuberous Sclerosis Lymphangioleiomyomatosis
Date: 2014-12-14
Recruiting Study Name: Treatment of Renal Angiomyolipomas in Tuberous Sclerosis by Beta-blockers
Condition: Renal Angiomyolipomas Tuberous Sclerosis
Date: 2014-04-01
Interventions: Drug: Propranolol
Withdrawn Study Name: A Phase II Study of Orally Administered BEZ235 Monotherapy in Patients With Metastatic or Unresectable Malignant PEComa
Condition: Malignant PEComa (Perivascular Epithelioid Cell Tumors)
Date: 2012-09-06
Interventions: Drug: BEZ235 Patients will be provided with an adequate supply of study treatment for self-administratio
Completed Study Name: Rapamycin In Angiomyolipomas In Patients With Tuberous Sclerosis
Condition: Angiomyolipoma
Date: 2010-10-06
Interventions: Drug: Sirolimus plasma levels between 4 and 8 Other
Completed Study Name: Long Term Follow Up for RAD001 Therapy of Angiomyolipomata in Patients With Tuberous Sclerosis (TSC) and Sporadic Lymphangioleiomyomatosis (LAM)
Condition: Tuberous Sclerosis Angiolipoma
Date: 2008-11-17
Interventions: Drug: everolimus (RAD001) Subjects will resume the dosing regimen that they were receiving at the comple
Completed Study Name: Efficacy and Safety of RAD001 in Patients Aged 18 and Over With Angiomyolipoma Associated With Either Tuberous Sclerosis Complex (TSC) or Sporadic Lymphangioleiomyomatosis (LAM)
Condition: Tuberous Sclerosis Complex (TSC) Lymphangioleiomyomatosis (LAM)
Date: 2008-11-10
Interventions: Drug: Everolimus (RAD001) Ever
Completed Study Name: Tuberous Sclerosis Complex Natural History Study: Renal Manifestations
Condition: Tuberous Sclerosis Complex
Date: 2007-12-27
Completed Study Name: RAD001 Therapy of Angiomyolipomata in Patients With TS Complex and Sporadic LAM
Condition: Tuberous Sclerosis Lymphangioleiomyomatosis
Date: 2007-04-06
Interventions: Drug: RAD001 5 and 10 mg/day or 30, 50, 70mg/week
Page 1 of 2
Next >>>

About

  • About Us
  • Terms of Use
  • Privacy Policy
  • Opt-Out & Information Removal
  • Contact Us
  • Advertising Privacy Policy
  • Sitemap

  • Webhealth Logo

Network Sites

  • DiabetesHealthMatters
  • HeartandStrokeHealth
  • WomensHealthCareCommunity
  • AsthmaHealthCenter
  • cancerHealthCenter
  • MentalHealthHelpCenter
  • OrthopedicsHealth
  • skincarehealthcenter
  • DigestiveTractHealth
  • VaccineHealthCenter
  • painHealthCenter
  • FightingAddictionCenter
  • ObesityHealthMatters
  • SeniorHealthcareMatters
  • BrainAndNerveCenter

Partner Offers

  • All Offer
  • US
  • Canadian
  • Latin America
  • European
  • Asia Pacific
  • Other

Additional

  • Advertise With Us
  • Our Brands

WebHealth Network

WebHealth Network is the leading aggregator of health, fitness, and wellness news and information from across the Web. We provide our readers with the deepest access to health information from the most trusted health publishers.

We aim to be a one stop for all the info you need to stay healthy.

Our sources include hundreds of blogs, health sites, government sites, pharmaceutical manufacturers and much more. All the information provided is publicly available and is updated daily.

Not a Substitute for Medical Advise

WebHealth Network is designed for educational purposes only. The information provided is not a substitute for professional medical advise, diagnoses, or treatment. If you are experiencing problems with your health, it is recommended that you consult a medical professional, doctor, or other health care professional. Do not delay or avoid seekeing medical advise from a professional because of any information listed on WebHealth Network. The use of the information provided on the site is at your own risk.

Ongoing medical research may change or impact the information listed on WebHealth Network. No assurances are provided that the information listed will include the most updated developments.

If you are you are experiencing a medical emergency, please call your health care professional immediately.